BBL Protect has been successful in securing investment from SFC Capital enabling the Company to move forward into production.
“This is amazing for us as a Company,” Said Russell Clifton, MD. “We have developed our products throughout the pandemic and faced a number of challenges in relation to supply and access to resources. This investment will now allow us to push forward into our next growth stage. We have a real World Evaluation taking place in March with the NHS, following which we will be moving to full production. There is a lot going on, and we have very exciting times ahead.”
